Cite
217 The impact of chemotherapy response score and lymphocytic infiltration in patients with ovarian cancer treated with neoadjuvant chemotherapy
MLA
Anastasia Prodromidou, et al. “217 The Impact of Chemotherapy Response Score and Lymphocytic Infiltration in Patients with Ovarian Cancer Treated with Neoadjuvant Chemotherapy.” Ovarian Cancer, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cff05c29dd7a85bc0888193711528526&authtype=sso&custid=ns315887.
APA
Anastasia Prodromidou, Dimitrios Haidopoulos, Aristotle Bamias, Michael Liontos, I. Rodolakis, A. Rodolakis, Dimitrios Loutradis, N. Thomakos, & M. Sotiropoulou. (2021). 217 The impact of chemotherapy response score and lymphocytic infiltration in patients with ovarian cancer treated with neoadjuvant chemotherapy. Ovarian Cancer.
Chicago
Anastasia Prodromidou, Dimitrios Haidopoulos, Aristotle Bamias, Michael Liontos, I. Rodolakis, A. Rodolakis, Dimitrios Loutradis, N. Thomakos, and M. Sotiropoulou. 2021. “217 The Impact of Chemotherapy Response Score and Lymphocytic Infiltration in Patients with Ovarian Cancer Treated with Neoadjuvant Chemotherapy.” Ovarian Cancer, October. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cff05c29dd7a85bc0888193711528526&authtype=sso&custid=ns315887.